@kewatson

Passionate about #Cardiology, #WIC, and #healthequity. PD @UCLACVfellows

 Professor of Cardiology UCLA
Joined November 2008
  • Tweets1.4K
  • Following1.2K
  • Followers2.1K
35Media
Karol Watson retweeted
NEJM Clinician@NEJMClinicianMay 29
Spontaneous coronary artery dissection associated with pregnancy appears more clinically severe and potentially less likely to result in a favorable recovery. Karol E. Watson, MD, PhD, FACC (@kewatson), summarizes a recent study: jwat.ch/3Rmjtyk
A text image from NEJM Clinician discussing a study. It states, "Reproductive history—particularly preeclampsia and assisted reproductive technology use—and older maternal age may help identify women at higher risk." Study by Karol E. Watson, M.D., Ph.D., F.A.C.C., Kozo A, et al. Published in JAMA Cardiol 2026 Mar 29.

ALT A text image from NEJM Clinician discussing a study. It states, "Reproductive history—particularly preeclampsia and assisted reproductive technology use—and older maternal age may help identify women at higher risk." Study by Karol E. Watson, M.D., Ph.D., F.A.C.C., Kozo A, et al. Published in JAMA Cardiol 2026 Mar 29.

2
5
834
#FlashbackFriday to our fellows covering our @UCLA IM residents on CCU, so they could enjoy their retreat! #Bruinhearts always showing up for each other and our house staff 💙💛💙 And many thanks to those similarly covering Memorial Day weekend 🫡🫀
1
4
32
3,391
Karol Watson retweeted
Sanjay Kaul@kaulcsmcApr 7
Replying to @NEJMClinician @kewatson @djc795
And Karol’s commentary on CHAMPION-AF is spot on, blunt but incisive! It is hard to see how anyone can look at the results and declare it is a win for Watchman FLX.
1
1
1
11
1,529
Karol Watson retweeted
Sanjay Kaul@kaulcsmcApr 7
Replying to @NEJMClinician @djc795 @kewatson
Excellent discussion! Not sure if the distinction between DM with atherosclerosis and without atherosclerosis subset in VESALIUS-CV is as sharp as the investigators’ claims. Baseline CV or all-cause deaths and treatment benefit is indistinguishable among the 2 groups.
1
1
3
736
Our very own @kewatson co-authored @CircAHA editorial calling 2026 dyslipidemia guidelines "a more precise individualized & equitable" framework for ASCVD prevention. ABC members co-wrote the guidelines. Now they're leading the conversation. buff.ly/CaKrb9D

Dr. Karol Watson Adds Expert Voice to National Dialogue on New Dyslipidemia Guidelines

As the cardiovascular community continues to unpack the newly released 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia, ABC is proud to highlight that former ABC Preventive...

abcardio.org
2
4
347
Karol Watson retweeted
Eric H Yang, MD@datsunianMar 30
#ACC26 finishes & as always proud of our @UCLAHealth presence, led by our housestaff & alumni! 🔥work with 25+ abstracts/talks/more 🙏 to the mentors who inspire them And congrats to @ACCinTouch 🌟#KatieBerlacher whose MedEd impact reaches farther than u will ever know ❤️
1
7
49
2,206
Karol Watson retweeted
JK Han MD@netta_docMar 28
Replying to @kewatson @docHJ @utmbcardiology
xitter.cf/bogdienache/status/203…
Bogdan Enache
@bogdienacheMar 28
Replying to @DrMarthaGulati @ACCinTouch @dranulala @purviparwani @iamritu
And everyone should make sure to understand what happens to the ischemic stroke risk in a device considered as an alternative to oral anticoagulation for stroke prevention.
1
6
952
It’s a #MATCH 💙🎊💛! Welcome to the newest members of our #Bruinhearts Family! We are so thrilled to have you all join us, and congratulations on your incredible achievements! The future of cardiology is bright and forever beats blue and gold ⭐️💫.
1
15
8
68
43,356
A BIG enthusiastic welcome to our new #bruinhearts @uclaCVfellows class!! We are so excited to have you join the family and be the field's next superstars!! @kewatson @netta_doc @HayaseJustin @arafiqmd1 @DOM_UCLA @IntMedAbel
UCLA Cardiology Fellowship@uclaCVfellows3 Dec 2025
It’s a #MATCH 💙🎊💛! Welcome to the newest members of our #Bruinhearts Family! We are so thrilled to have you all join us, and congratulations on your incredible achievements! The future of cardiology is bright and forever beats blue and gold ⭐️💫.
8
56
6,091
Replying to @rblument1
@rblument1 presenting at #AHA25 on the intensity & timing of LDL lowering 🫀elevated LDL exposure time matters 🫀risk scores don’t go young enough- waiting to 40 to treat may be too late 🫀don’t wait: cross the line early @CiccaroneCenter @MichaelJBlaha @SethShayMartin @drstaceyrosen
9
30
1,574
CORE TIMi 72a/b presented as #LBCT #AHA25 studying olezarsen in severe hypertriglyceridemia with primary endpoint percent change in TG ♥️ Global study 1063 patients ♥️placebo compared with two doses ♥️1/4 female 👎🏽 🎯62% placebo control ⤵️ in TG 🎯 significant ⤵️ in non HDL: many achieved TG <150 & 85% <500! 👏🏽 🎯⤵️ in pancreatitis with tx NNT=4 🎯 safe esp at 50 mg dose 📎 nejm.org/doi/full/10.1056/NE… @ionispharma @NEJM
2
10
27
2,883
Replying to @DrMarthaGulati @iamritu @purviparwani @AHAScience @kewatson @JoChikweMD @dramitkhera
2 studies with impressive results of major reduction in Triglycerides and its effects in pts with high TG
2
1
7
2,185
Congrats & so thrilled for @UCLAHealthJCCC @UCLAHealth @DOM_UCLA #bruinhearts @ucla_wic @A_SteinMerlob winning the #YIA at #GCOS2025! 🙏 to @alan_garfinkel, @uclaCVfellows @kewatson @IntMedAbel #STAR leadership for your amazing mentorship for this #cardioonc🌟! @ICOSociety
International Cardio-Oncology Society
@ICOSociety31 Oct 2025
Congrats to Ashley Stein-Merlob, the winner of the #GCOS2025 #YoungInvestigators Award 🏆! Three talented Young Investigators, Ashley 🇺🇸, Hiroki Yoshida 🇯🇵, and Stephen Rankin 🇬🇧 had the opportunity to present their research to the #cardiooncologists gathered at this year's #GCOS. With these three at the helm, the future of #cardiooncology is looking bright 🤩 #cardioonc
1
5
18
1,979
Look Carefully for Causes of Myocardial Infarction in Younger Patients: jwat.ch/4oGfrwf @kewatson #CardioTwitter
3
14
1,600
Remarkable contributions to the field expanding a life saving therapy-great to see the two legends on the stage for 20th Annual VT Symposium- Mark Josephson Memorial Lecture. Our beloved Mark would indeed be smiling! @DrRoderickTung @VTSymposium
erica zado@EricaZado11 Oct 2025
2 legends in EP! Frank Marchlinski and Paolo Della Bella after Dr. Della Bella gave the Mark Josephson Memorial Lecture. Wonderful lecture as tribute to yet another giant in EP. @vtsymposium @DrRoderickTung
3
4
1
39
6,411
So lovely to spend time with some of our favorite people! Lovely to be able to have a hike & breakfast with @rblument1 & @WendyPost9 today before their wedding they are attending tonight & before @SmidtHeart GR on Tuesday! We loved being able to see you both! #CVPrev & #friendship are some of the best things in life!
1
3
2
57
9,268
Karol Watson retweeted
Gregg Fonarow MD@gcfmd3 Oct 2025
Amgen announced the Phase 3 VESALIUS-CV clinical trial met its dual primary endpoints demonstrating that evolocumab significantly reduced the risk of MACE in individuals without a prior history of heart attack or stroke 12,000 high-risk patients, median of 4.5 years @kewatson
2
6
22
1,901
Data from the COMBINE-AF substudy suggest it may be safe and beneficial to switch frail older patients with atrial fibrillation from warfarin to a direct-acting oral anticoagulant. jwat.ch/4nQWyGo #CardioTwitter @kewatson
4
11
2,003
Statins have been contraindicated during pregnancy because of teratogenic effects in animal studies. Now, using Norwegian registry data, researchers have evaluated statin exposure and congenital malformations in more than 800,000 pregnancies. jwat.ch/3K9fCRE @kewatson
3
12
3
44
12,867
A privilege to listen to GDMT masterclass with Dr Gregg Fonarow @gcfmd at @UCLA_HF Symposium Evidence, nuance, and practical takeaways for #HFmrEF #HFpEF care
4
29
1,396
Load more